Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Bioinformatics Firm OmicSoft

NEW YORK (GenomeWeb) – Qiagen today announced it has acquired bioinformatics firm OmicSoft for an undisclosed amount of cash.

OmicSoft markets a suite of tools that allow researchers to analyze and visualize data and compare them to large, publicly available multi-omics data sets. Qiagen said the acquisition will provide it with scalable and flexible software architecture solutions that will enable it to expand its bioinformatics offerings.

"Through the addition of OmicSoft, Qiagen will now offer solutions across the full spectrum of data management and interpretation needs," the firm said in a statement. 

OmicSoft will operate as a Qiagen subsidiary from its Research Triangle, North Carolina headquarters and its co-founder and president, Jack Liu, will remain with Qiagen.

Qiagen said that it expects 0.5 percent in incremental sales growth on a full-year basis and that the purchase will be neutral to adjusted EPS.

This is the latest acquisition for Qiagen since it completed a tender offer for Danish molecular diagnostics firm Exiqon last June. 

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.